Centene EBIT 2012-2026 | CNC
Centene annual and quarterly EBIT history from 2012 to 2026. EBIT can be defined as earnings before interest and taxes.
- Centene EBIT for the quarter ending March 31, 2026 was $1.861B, a 21.32% increase year-over-year.
- Centene EBIT for the twelve months ending March 31, 2026 was $-7.296B, a 302.5% decline year-over-year.
- Centene 2025 annual EBIT was $-7.623B, a 340.09% decline from 2024.
- Centene 2024 annual EBIT was $3.175B, a 8.36% increase from 2023.
- Centene 2023 annual EBIT was $2.93B, a 122.31% increase from 2022.
|
Centene Annual EBIT (Millions of US $) |
|
|---|---|
| 2025 | $-7,623 |
| 2024 | $3,175 |
| 2023 | $2,930 |
| 2022 | $1,318 |
| 2021 | $1,784 |
| 2020 | $3,082 |
| 2019 | $1,781 |
| 2018 | $1,458 |
| 2017 | $1,199 |
| 2016 | $1,263 |
| 2015 | $705 |
| 2014 | $464 |
| 2013 | $277 |
| 2012 | $108 |
| 2011 | $204 |
|
Centene Quarterly EBIT (Millions of US $) |
|
|---|---|
| 2026-03-31 | $1,861 |
| 2025-12-31 | $-1,745 |
| 2025-09-30 | $-6,954 |
| 2025-06-30 | $-458 |
| 2025-03-31 | $1,534 |
| 2024-12-31 | $175 |
| 2024-09-30 | $665 |
| 2024-06-30 | $1,229 |
| 2024-03-31 | $1,106 |
| 2023-12-31 | $-194 |
| 2023-09-30 | $735 |
| 2023-06-30 | $1,171 |
| 2023-03-31 | $1,218 |
| 2022-12-31 | $-282 |
| 2022-09-30 | $476 |
| 2022-06-30 | $-129 |
| 2022-03-31 | $1,253 |
| 2021-12-31 | $603 |
| 2021-09-30 | $545 |
| 2021-06-30 | $-418 |
| 2021-03-31 | $1,054 |
| 2020-12-31 | $15 |
| 2020-09-30 | $861 |
| 2020-06-30 | $2,018 |
| 2020-03-31 | $188 |
| 2019-12-31 | $277 |
| 2019-09-30 | $176 |
| 2019-06-30 | $643 |
| 2019-03-31 | $685 |
| 2018-12-31 | $388 |
| 2018-09-30 | $41 |
| 2018-06-30 | $489 |
| 2018-03-31 | $540 |
| 2017-12-31 | $181 |
| 2017-09-30 | $340 |
| 2017-06-30 | $438 |
| 2017-03-31 | $240 |
| 2016-12-31 | $524 |
| 2016-09-30 | $342 |
| 2016-06-30 | $377 |
| 2016-03-31 | $20 |
| 2015-12-31 | $220 |
| 2015-09-30 | $183 |
| 2015-06-30 | $173 |
| 2015-03-31 | $129 |
| 2014-12-31 | $193 |
| 2014-09-30 | $108 |
| 2014-06-30 | $93 |
| 2014-03-31 | $70 |
| 2013-12-31 | $85 |
| 2013-09-30 | $84 |
| 2013-06-30 | $69 |
| 2013-03-31 | $40 |
| 2012-12-31 | $148 |
| 2012-09-30 | $-28 |
| 2012-06-30 | $-47 |
| 2012-03-31 | $34 |
| 2011-12-31 | $61 |
| 2011-09-30 | $49 |
| 2011-06-30 | $55 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Health Maintenance Organizations | $18.343B | $194.777B |
| Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Through a diversified product portfolio and expanding geographic reach, Centene continues to deliver results by growing premium and service revenues profitably. The company operates in two segments: Managed Care and Specialty Services. Managed Care - This segment provides health plan coverage to individuals through Government subsidized programs, including Medicaid. Specialty Services - This segment consists of its specialty companies offering diversified healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UnitedHealth Group (UNH) | United States | $276.233B | 18.66 |
| Cigna Group (CI) | United States | $71.482B | 9.09 |
| Humana (HUM) | United States | $23.068B | 11.22 |
| Molina Healthcare (MOH) | United States | $7.599B | 13.70 |
| Select Medical Holdings (SEM) | United States | $2.030B | 14.23 |
| Joint (JYNT) | United States | $0.125B | 0.00 |
| Aethlon Medical (AEMD) | United States | $0.003B | 0.00 |